The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Effects of Central Interleukin-1 on the Cardiovascular Response in Hemorrhaged Rats

  • Kang, Joon-Ho (Department of Physiology, School of Medicine, Kyungpook National University) ;
  • Jang, Jae-Hee (Department of Physiology, School of Medicine, Kyungpook National University) ;
  • Ahn, Dong-Kuk (Department of Oral Physiology, School of Dentistry, Kyungpook National University) ;
  • Park, Jae-Sik (Department of Physiology, School of Medicine, Kyungpook National University)
  • Published : 2004.04.21
Download PDF
⟨ Previous Next ⟩

Abstract

The arterial pressure is regulated by the nervous and humoral mechanisms. The neuronal regulation is mostly carried out by the autonomic nervous system through the rostral ventrolateral medulla (RVLM), a key area for the cardiovascular regulation, and the humoral regulation is mediated by a number of substances, including the angiotensin (Ang) II and vasopressin. Recent studies suggest that central interleukin-1 (IL-1) activates the sympathetic nervous system and produces hypertension. The present study was undertaken to elucidate whether IL-1 and Ang II interact in the regulation of cardiovascular responses to the stress of hemorrhage. Thus, Sprague-Dawley rats were anesthetized and both femoral arteries were cannulated for direct measurement of arterial pressure and heart rate (HR) and for inducing hemorrhage. A guide cannula was placed into the lateral ventricle for injection of IL-1 $(0.1,\;1,\;10,\;20\;ng/2\;{\mu}l)$ or Ang II $(600\;ng/10\;{\mu}l)$. A glass microelectrode was inserted into the RVLM to record the single unit spike potential. Barosensitive neurons were identified by an increased number of single unit spikes in RVLM following intravenous injection of nitroprusside. I.c.v. $IL-1\;{\beta}$ increased mean arterial pressure (MAP) in a dose-dependent fashion, but HR in a dose-independent pattern. The baroreceptor reflex sensitivity was not affected by i.c.v. $IL-1\;{\beta}$. Both i.c.v. $IL-1\;{\alpha}\;and\;{\beta}$ produced similar increase in MAP and HR. When hemorrhage was induced after i.c.v. injection of $IL-1\;{\beta}$, the magnitude of MAP fall was not different from the control. The $IL-1\;{\beta}$ group showed a smaller decrease in HR and a lower spike potential count in RVLM than the control. MAP fall in response to hemorrhage after i.c.v. injection of Ang II was not different from the control. When both IL-1 and Ang II were simultaneously injected i.c.v., however, MAP fall was significantly smaller than the control, and HR was increased rather than decreased. These data suggest that IL-1, a defense immune mediator, manifests a hypertensive action in the central nervous system and attenuates the hypotensive response to hemorrhage by interaction with Ang II.

Keywords

References

  1. Aggarwal BB, Pocsik E. Cytokines: from clone to clinic. Arch Biochem Biophys 292: 335-359, 1992 https://doi.org/10.1016/0003-9861(92)90002-E
  2. Ahn DK, Cheon DW, Park YY, Kim HJ, Park JS, Lee WJ. Effects of intracerebroventricular angiotensin II on the response to hemorrhage in conscious normotensive and hypertensive rats. J Kor Soc Endocrinol 8: 141-148, 1993
  3. Andreis PG, Neri G, Meneghelli V, Mazzocchi G, Nussdorfer GG. Effects of interleukin-1 beta on the renin-angiotensin- aldosterone system in rats. Res Exp Med (Berl) 192: 1-6, 1992 https://doi.org/10.1007/BF02576251
  4. Audoly LP, Ruan X, Wagner VA, Goulet JL, Tilley SL, Koller BH, Coffman TM, Arendshorst WJ. Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics. Am J Physiol 280: H327-333, 2001
  5. Bataillard A, Sassard J. Cardiovascular effects of human recombinant interleukin-1 beta in conscious rats. Am J Physiol 266: R1148-1153, 1994
  6. Calapai G, Marciano MC, Costantino G, Russo A, Corica F, Sautebin L, Di Rosa M, Caputi AP. Effects of water deprivation and angiotensin II intracerebroventricular administration on brain nitric oxide synthase activity. Eur J Pharmacol 360: 147- 154, 1998 https://doi.org/10.1016/S0014-2999(98)00672-4
  7. Dampney RAL. The subretrofacial vasomotor nucleus: anatomical, chemical and pharmacological properties and role in cardiovascular regulation. Prog Neurobiol 42: 197-227, 1994 https://doi.org/10.1016/0301-0082(94)90064-7
  8. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 77: 1627-1652, 1991
  9. Dinarello CA. Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism. Int J Tissue React 14: 65-75, 1992
  10. Guyenet PG. Role of the ventral medulla oblongata in blood pressure regulation. In: Loewy AD, Spyer KM ed, Central Regulation of Autonomic Functions. Oxford, New York, p 145- 167, 1990
  11. Haefeli WE, Bargetzi MJ, Starnes HF, Blaschke TF, Hoffman BB. Evidence for activation of the sympathetic nervous system by recombinant human interleukin-1 beta in humans. J Immunother 13: 136-140, 1993 https://doi.org/10.1097/00002371-199302000-00009
  12. Harding P, Sigmon DH, Alfie ME, Huang PL, Fishman MC, Beierwaltes WH, Carretero OA. Cyclooxygenase-2 mediates increased renal renin content induced by low-sodium diet. Hypertension 29: 297-302, 1997 https://doi.org/10.1161/01.HYP.29.1.297
  13. Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol 281: F1-11, 2001 https://doi.org/10.1152/ajpcell.2001.281.1.C1
  14. Hashimoto K, Hirasawa R, Makino S. Comparison of the effects of intra-third ventricular administration of interleukin-1 or platelet activating factor on ACTH secretion and the sympatheticadrenomedullary system in conscious rats. Acta Med Okayama 47: 1-6, 1993
  15. Kannan H, Tanaka Y, Kunitake T, Ueta Y, Hayashida Y, Yamashita H. Activation of sympathetic outflow by recombinant human interleukin-1 beta in conscious rats. Am J Physiol 270: R479-485, 1996
  16. Kaplan E, Dinarello CA, Wakabayashi G, Burke JF, Connolly RS, Gelfand JA. Interleukin-1 pretreatment protects against endotoxin-induced hypotension in rabbits: association with decreasedtumor necrosis factor levels. J Infect Dis 167: 244-247, 1993 https://doi.org/10.1093/infdis/167.1.244
  17. Kimura T, Yamamoto T, Ota K, Shoji M, Inoue M, Sato K, Ohta M, Funyu T, Yoshinaga K. Central effects of interleukin-1 on blood pressure, thermogenesis, and the release of vasopressin, ACTH, and atrial natriuretic peptide. Ann NY Acad Sci 689: 330 -345, 1993 https://doi.org/10.1111/j.1749-6632.1993.tb55558.x
  18. Mistry M, Nasjletti A. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension. Hypertension 11: 758- 762, 1988 https://doi.org/10.1161/01.HYP.11.6.758
  19. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS. Rapid and specific conversion of precursor interleukin-1$\beta$ (IL-1$\beta$) to an active IL-1 species by human mast cell chymase. J Exp Med 174: 821-825, 1991 https://doi.org/10.1084/jem.174.4.821
  20. Morimoto K, Morimoto A, Nakamori T, Tan N, Minagawa T, Murakami N. Cardiovascular responses induced in free-moving rats by immune cytokines. J Physiol Lond 448: 307-320, 1992 https://doi.org/10.1113/jphysiol.1992.sp019043
  21. Olsen ME, Hall JE, Montani JP, Cornell JE. Protection of preglomerular vessels from angiotensin II vasoconstriction by renal prostaglandins. J Hypertens 3(Suppl 3): S255-258, 1985 https://doi.org/10.1097/00004872-198506000-00010
  22. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. Academic Press, California, USA, 1986
  23. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 110: 61- 69, 2002 https://doi.org/10.1172/JCI0214752
  24. Raij L, Baylis C. Nitric oxide and the glomerulus. Kidney Int 48: 20-32, 1995 https://doi.org/10.1038/ki.1995.262
  25. Takahashi H, Nishimura M, Sakamoto M, Ikegaki I, Nakanishi T, Yoshimura M. Effects of interleukin-1 beta on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats. Am J Hypertens 5: 224-229, 1992 https://doi.org/10.1093/ajh/5.4.224
  26. Traynor TR, Smart A, Briggs JP, Schnermann J. Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2. Am J Physiol 277: F706-710, 1999
  27. Ullman J. Influence of neurohumoral blockade on heart rate and blood pressure responses to haemorrhage in isoflurane anaesthetized rats. Acta Physiol Scand 169: 189-194, 2000 https://doi.org/10.1046/j.1365-201x.2000.00734.x
  28. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63: 289-302, 1995 https://doi.org/10.1016/0304-3959(95)00186-7
  29. Weinberg JR, Boyle P, Meager A, Guz A. Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. J Lab Clin Med 120: 205-211, 1992
  30. Weinberg JR, Wright DJ, Guz A. Interleukin-1 and tumour necrosis factor cause hypotension in the conscious rabbit. Clin Sci (Colch) 75: 251-255, 1988 https://doi.org/10.1042/cs0750251
  31. Yamamoto T, Kimura T, Ota K, Shoji M, Inoue M, Ohta M, Sato K, Funyu T, Abe K. Effects of interleukin-1 beta on blood pressure, thermoregulation, and the release of vasopressin, ACTH and atrial natriuretic hormone. Tohoku J Exp Med 173: 231-245, 1994 https://doi.org/10.1620/tjem.173.231
  32. Zhang Y, Guan Y, Schneider A, Brandon S, Breyer RM, Breyer MD. Characterization of murine vasopressor and vasodepressor prostaglandin E2 receptors. Hypertension 35: 1129-1134, 2000 https://doi.org/10.1161/01.HYP.35.5.1129